The FDA’s vaccine advisory committee unanimously recommended a monovalent JN.1-lineage COVID-19 vaccine for the 2024-2025…
The FDA’s vaccine advisory committee unanimously recommended a monovalent JN.1-lineage COVID-19 vaccine for the 2024-2025…